|
|
|
Saturday, March 20, 2010 — 7:00 PM, Wilson
|
- Advances in Corneal and Conjunctival Pathology
|
|
Moderator:
|
Charles G. Eberhart, Johns Hopkins University School of Medicine, Baltimore, MD
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 7:00 | Introduction - Charles G. Eberhart, Johns Hopkins University School of Medicine, Baltimore, MD |
| 7:10 | Corneal Specimens that Influence Clinical Decisions; Refractive Surgery, Corneal Dystrophy, and Microbial Infection - J. Douglas Cameron, Mayo Clinic, Rochester, MN |
| 7:45 | Advances in Melanocytic Lesions of Conjunctiva - Codrin E. Iacob, New York Eye and Ear Infirmary, New York, NY |
| 8:20 | Melanocytic Lesions of Conjunctiva - WT1 and Bc12 As Useful Markers - Emiko Furusato, Armed Forces Institute of Pathology, Washington, DC |
| 8:40 | Squamous and Sebaceous Lesions of Conjunctiva - Advances in Immunohistochemical Markers - Charles G. Eberhart, Johns Hopkins University School of Medicine, Baltimore, MD |
| 9:00 | Advances in Non-Neoplastic Conjunctival Disease - Inflammation, Infection, Degenerations and Deposits - Tatyanan Milman, New York Eye and Ear Infirmary, New York, NY |
| 9:35 | Panel Discussion |
The USCAP-Companion meeting committee for the AAOP (Hans Grossniklaus MD, Douglas Cameron MD, and Paty Chevez Barrios, MD) discussed the reviews from the 2009 meeting, reviewed topics that were presented in prior years, and reviewed previous presenters in a series of conference calls and email exchanges. After a thorough review, we concluded that our audience would be interested in Advances in Corneal and Conjunctival Pathology. Dr. Eberhart was selected as Program Chair, and together with the committee he chose members of our organization with expertise in these topics and invited them to be speakers.
The goals and objectives for this meeting are to provide and update on new advances in ophthalmic pathology that the audience will find useful in their pathology practice. This will include presentations on new immunohistochemical marker studies, as well as discussions of new staging systems for neoplasms at these sites. The speakers have been chosen due to their expertise in these areas.
|
|
|
|
